MiPod Nuclear is in licensing deal for isotope technology

10/20/2010 | Yahoo!

MiPod Nuclear has entered a licensing deal that gives Vector Trading exclusive rights to its patent-pending technology for the production of Mo-99 medical isotope. The agreement covers the use of the technology, which will employ depleted uranium in its procedure, in Australia and New Zealand.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX